Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259-267

Diabetologia. 2007 Jul;50(7):1561-2; author reply 1563-4. doi: 10.1007/s00125-007-0653-9. Epub 2007 Mar 24.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Blood Pressure
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Therapy, Combination
  • Exenatide
  • Glycated Hemoglobin A / metabolism
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*
  • Lipids / blood
  • Metformin / therapeutic use*
  • Peptides / therapeutic use*
  • Research Design
  • Sulfonylurea Compounds / therapeutic use
  • Venoms / therapeutic use*

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Lipids
  • Peptides
  • Sulfonylurea Compounds
  • Venoms
  • Metformin
  • Exenatide